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Shelf of curiosities: Dr Sharma with part of UPM’s national parasite reference collection. Jars of 
parasites dating back to the 1970s are stored at the building’s parasitology lab. Current 
research focuses on P. knowlesi, a type of simian malaria shown to be an emerging zoonotic 
disease. 
A deadly malarial strain has made the leap from monkeys to humans, and Malaysia 
is at the forefront of the research. 
A SHELVING unit running across the length of a wall draws curious stares to its collection of 
bottled curiosities: a pickled cow hoof, floating specimens of parasitic helminths, tangles of 
worm-like ascaris, muscle tissue dotted with sarcocystis, and at the far right corner, a collection 
of Anopheles mosquitoes suspended in a clear viscous substance. 
“We’re trying to set up a national parasite reference collection,” explains Dr Reuben Sharma. 
Not many people visit this parasitology lab, headed by Dr Sharma and tucked away in a remote 
corner of Universiti Putra Malaysia’s (UPM) Faculty of Veterinary Medicine in Serdang, Selangor. 
But the work being done here is of national importance. 
In some ways, UPM is the new kid on the block, having recently joined other research 
institutions in the country working on a deadly, emerging malaria parasite – Plasmodium 
knowlesi. 
Caused by microscopic single-celled organisms known as plasmodia, it’s not as bad as it sounds. 
A malarial infection of this kind is only deadly if not treated, and malaria drugs are widely 
available. 
The trick is knowing you have it. And that’s what makes P. knowlesi so interesting. Up until 
about 10 years ago, no one had any idea that humans could get infected. 
There were four human malaria parasites, and P. knowlesi was not one of them, hitherto known 
only to infect monkeys. 
Primary contributor 
That is, until eminent Sarawak-based parasitologist Dr Balbir Singh got curious about some 
statistics. 
Having spent many years studying malaria at the Liverpool School of Tropical Medicine, Britain, 
Dr Balbir believed in academia with a focus – and his focus was malaria, although mostly 
involving human malarias. 
His research, however, is one of the main reasons we now know that the biggest contributor of 
Malaysia’s hospitalised malaria cases is not human malaria, but P. knowlesi. 
In 1999, he and his wife Dr Janet Cox-Singh started work at the Faculty of Medicine & Health 
Sciences, Universiti Malaysia Sarawak (Unimas). While trawling data to get acquainted with 
malaria transmission dynamics in Sarawak, they noticed an anomaly, and decided to 
investigate. 
This was the problem: in Kapit, a relatively inaccessible town on the banks of the Rajang river 
in Sarawak’s vast Kapit division, people were being hospitalised for P. malariae. 
This was strange for two reasons. One, P. malariae symptoms are mild, hospitalisations are 
very unusual. And two, very few of the patients were children – usually the most vulnerable to 
severe infections through a lack of acquired immunity. Dr Balbir was baffled why 95% of the 
cases reported involved adults. 
So Dr Balbir packed his bags and went to Kapit, drawing blood samples from sick patients at 
the hospital. 
Under the microscope, the plasmodia did indeed look like P. malariae. But when Dr Balbir 
turned to DNA-based detection, the plot thickened. The samples tested negative for any of the 
four parasites known to infect humans – P. malariae, P. falciparum, P. vivax and P. ovale – but 
tested positive for . 
In other words, it was malaria all right – just not a form of human malaria. 
Eventually, when he ran the DNA sequence information gathered from his team’s research 
through the DNA database, P. knowlesi showed up as a complete match. 
Pandora’s Box 
That moment determined the course of Dr Balbir and Dr Cox-Singh’s research for the next 
decade, and beyond. It has also put Malaysia at the forefront of investigations into P. knowlesi. 
Their team at the Malaria Research Centre at Unimas developed a molecular detection test for 
the parasite, and launched a study. They travelled to hospitals scattered throughout Sarawak, 
as well as longhouses in the interior, in order to find out how widespread the disease was. 
Four years, two hundred patients and one publication in leading medical journal The Lancet 
later, the world was in for a surprise: a fifth human malaria had emerged on the scene. 
Of all the malaria cases observed in the Kapit division, 58% were caused by the simian or 
monkey malaria P. knowlesi. 
Once the news emerged, cases began popping up all over South-East Asia, in areas that are 
home to both its macaque hosts and Anopheles mosquito vectors. The team published a second 
study in 2008, which showed that P. knowlesi was not restricted to Sarawak either; cases have 
been confirmed in Sabah and Pahang too. More importantly, the medical community took notice 
when they reported that P. knowlesi could lead to fatal infections. 
So far, Malaysia has the highest number of cases, but that’s probably because it is the only 
country where there has been a focused scientific drive to study it with molecular detection 
tools. 
But why is P. knowlesi even important? 
Most cases happen to people who live or work in the jungle, or adventurers coming out of it. 
Right? 
Killers in the blood 
Here’s why it matters: some malaria parasites are more dangerous than others. 
P. falciparum for example, is a killer. 
P. vivax is not as bad, but it is a potential killer, and can be severely debilitating. 
P. malariae – which Dr Balbir discovered looks a lot like P. knowlesi under a microscope – and 
P. ovale don’t do too much damage. 
What makes some forms of Plasmodium infections deadlier than others is the ability and speed 
with which the parasite replicates within the blood. 
When Plasmodium first infects a human, it migrates to the liver and transforms into a new form 
capable of tunnelling into red blood cells, eventually exploding out of your liver cells into the 
bloodstream. 
Tens of thousands of individual parasites then penetrate your body’s red blood cells, stealing 
their nutrients and replicating like crazy, before surging forth in great numbers to invade yet 
more red blood cells. Without prompt treatment, a bad case of malaria will lead to severe fever, 
muscle pain and chills. 
For P. malariae, a fresh invasion occurs every 72 hours. 
In P. knowlesi however, the red blood cells burst open with new parasites every 24 hours. 
Each assault is synchronised, which is why malaria is associated with periodic fevers. 
Your body’s temperature rises as your immune system reacts to the shock. 
With every replication cycle, the patient grows weaker, left with fewer red blood cells to pass 
oxygen around the body. This puts stress on organs such as the heart and lungs, leaving 
victims struggling for breath. 
High parasite counts within the blood are part of what makes P. falciparum deadly. 
And from the limited experience with human case studies, P. knowlesi infections can involve a 
comparable, if not higher, parasite count than P. falciparum. 
That’s one reason why knowing more about P. knowlesi is important. 
For one thing, we need to make sure our healthcare systems – especially in rural jungle regions 
– are fully aware of this new threat. 
The severity of an infection will vary from patient to patient. Unfortunately, a microscopy-based 
misdiagnosis of P. malariae can prove deadly, and probably has in the past. 
In 2011, the World Health Organisation (WHO) facilitated an informal consultation on the public 
health importance of P. knowlesi. 
One of its recommendations was to treat any case diagnosed by microscopy as P. malariae with 
the possibility that it may also be P. knowlesi as a guide to case management. This has since 
been adopted by Malaysia’s health care system. WHO also acknowledged that surveillance is 
needed to detect whether or not any human-to-human transmission is occurring. 
If it is, that would be a big blow to global ambitions for malaria eradication. 
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